InMode (INMD) Competitors $17.08 -0.11 (-0.64%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipShort InterestTrends INMD vs. INSP, PRCT, AXNX, NVCR, NVST, NARI, IRTC, LIVN, ENOV, and WRBYShould you be buying InMode stock or one of its competitors? The main competitors of InMode include Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Axonics (AXNX), NovoCure (NVCR), Envista (NVST), Inari Medical (NARI), iRhythm Technologies (IRTC), LivaNova (LIVN), Enovis (ENOV), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry. InMode vs. Inspire Medical Systems PROCEPT BioRobotics Axonics NovoCure Envista Inari Medical iRhythm Technologies LivaNova Enovis Warby Parker InMode (NASDAQ:INMD) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, community ranking and media sentiment. Which has preferable earnings and valuation, INMD or INSP? InMode has higher earnings, but lower revenue than Inspire Medical Systems. InMode is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInMode$423.75M3.39$197.92M$1.859.23Inspire Medical Systems$755.59M7.45-$21.15M$1.07175.49 Does the media prefer INMD or INSP? In the previous week, Inspire Medical Systems had 3 more articles in the media than InMode. MarketBeat recorded 7 mentions for Inspire Medical Systems and 4 mentions for InMode. InMode's average media sentiment score of 1.42 beat Inspire Medical Systems' score of 1.40 indicating that InMode is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InMode 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inspire Medical Systems 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in INMD or INSP? 68.0% of InMode shares are held by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are held by institutional investors. 6.9% of InMode shares are held by company insiders. Comparatively, 4.1% of Inspire Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more volatility and risk, INMD or INSP? InMode has a beta of 2.07, indicating that its stock price is 107% more volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 1.31, indicating that its stock price is 31% more volatile than the S&P 500. Does the MarketBeat Community believe in INMD or INSP? Inspire Medical Systems received 27 more outperform votes than InMode when rated by MarketBeat users. However, 73.73% of users gave InMode an outperform vote while only 61.31% of users gave Inspire Medical Systems an outperform vote. CompanyUnderperformOutperformInModeOutperform Votes16073.73% Underperform Votes5726.27% Inspire Medical SystemsOutperform Votes18761.31% Underperform Votes11838.69% Do analysts rate INMD or INSP? InMode presently has a consensus price target of $22.60, indicating a potential upside of 32.32%. Inspire Medical Systems has a consensus price target of $233.58, indicating a potential upside of 24.40%. Given InMode's higher probable upside, equities research analysts plainly believe InMode is more favorable than Inspire Medical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InMode 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33Inspire Medical Systems 0 Sell rating(s) 3 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.75 Is INMD or INSP more profitable? InMode has a net margin of 36.26% compared to Inspire Medical Systems' net margin of 4.37%. InMode's return on equity of 21.46% beat Inspire Medical Systems' return on equity.Company Net Margins Return on Equity Return on Assets InMode36.26% 21.46% 19.19% Inspire Medical Systems 4.37%5.30%4.58% SummaryInMode beats Inspire Medical Systems on 10 of the 18 factors compared between the two stocks. Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Get InMode News Delivered to You Automatically Sign up to receive the latest news and ratings for INMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INMD vs. The Competition Export to ExcelMetricInModeElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.43B$3.01B$5.07B$9.08BDividend YieldN/A1.75%4.87%4.21%P/E Ratio9.2316.1599.0517.15Price / Sales3.3950.121,121.17116.80Price / Cash8.4239.9141.5237.88Price / Book2.563.724.754.78Net Income$197.92M$89.83M$119.33M$225.60M7 Day Performance-6.46%-1.82%-1.86%-1.23%1 Month Performance-7.60%0.28%11.40%3.07%1 Year Performance-24.89%4.10%30.26%16.48% InMode Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INMDInMode3.6286 of 5 stars$17.08-0.6%$22.60+32.3%-21.7%$1.43B$423.75M9.23480Positive NewsINSPInspire Medical Systems4.6549 of 5 stars$188.38+0.3%$233.58+24.0%+1.7%$5.65B$755.59M176.781,011Positive NewsPRCTPROCEPT BioRobotics2.7844 of 5 stars$90.19+1.1%$97.86+8.5%+102.9%$4.71B$136.19M0.00626Positive NewsAXNXAxonics1.4257 of 5 stars$70.98+0.8%$71.00+0.0%+20.9%$3.63B$366.38M-591.45610High Trading VolumeNVCRNovoCure2.7417 of 5 stars$32.91-1.5%$32.67-0.7%+138.4%$3.56B$577.74M-23.861,453NVSTEnvista3.9012 of 5 stars$19.56+0.5%$20.65+5.6%-21.1%$3.37B$2.50B-2.5112,800Positive NewsNARIInari Medical3.3152 of 5 stars$55.67+0.1%$58.89+5.8%-11.9%$3.26B$574.50M-41.181,300Analyst ForecastInsider TradeIRTCiRhythm Technologies3.2276 of 5 stars$90.08+4.2%$107.82+19.7%-14.3%$2.82B$492.68M-17.782,000Analyst ForecastGap DownLIVNLivaNova3.6252 of 5 stars$50.01-2.9%$69.17+38.3%-4.4%$2.72B$1.24B122.622,900Analyst UpgradePositive NewsENOVEnovis3.0125 of 5 stars$46.91+1.7%$67.00+42.8%-21.5%$2.62B$2.00B-21.396,550Positive NewsWRBYWarby Parker1.5745 of 5 stars$24.22+2.5%$20.73-14.4%+99.1%$2.46B$669.77M-87.523,491Insider Trade Related Companies and Tools Related Companies INSP Alternatives PRCT Alternatives AXNX Alternatives NVCR Alternatives NVST Alternatives NARI Alternatives IRTC Alternatives LIVN Alternatives ENOV Alternatives WRBY Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:INMD) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMode Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMode With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
